Biotricity (BTCY) Competitors $0.41 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends BTCY vs. APYX, CODX, SURG, FEMY, STIM, DRIO, OM, MDAI, XAIR, and NXLShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Apyx Medical (APYX), Co-Diagnostics (CODX), SurgePays (SURG), Femasys (FEMY), Neuronetics (STIM), DarioHealth (DRIO), Outset Medical (OM), Spectral AI (MDAI), Beyond Air (XAIR), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. Biotricity vs. Apyx Medical Co-Diagnostics SurgePays Femasys Neuronetics DarioHealth Outset Medical Spectral AI Beyond Air Nexalin Technology Apyx Medical (NASDAQ:APYX) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends. Does the MarketBeat Community prefer APYX or BTCY? Apyx Medical received 78 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 60.94% of users gave Apyx Medical an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% BiotricityOutperform VotesNo VotesUnderperform Votes1100.00% Do insiders and institutionals believe in APYX or BTCY? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 16.8% of Apyx Medical shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate APYX or BTCY? Apyx Medical presently has a consensus target price of $5.00, indicating a potential upside of 320.17%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts clearly believe Apyx Medical is more favorable than Biotricity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger earnings & valuation, APYX or BTCY? Biotricity has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$52.35M0.79-$18.71M-$0.82-1.45Biotricity$12.06M0.77-$14.09M-$1.74-0.24 Is APYX or BTCY more profitable? Apyx Medical has a net margin of -57.86% compared to Biotricity's net margin of -117.42%. Biotricity's return on equity of 0.00% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-57.86% -105.45% -36.80% Biotricity -117.42%N/A -242.92% Which has more risk & volatility, APYX or BTCY? Apyx Medical has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Does the media prefer APYX or BTCY? In the previous week, Biotricity had 1 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for Biotricity and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.31 beat Biotricity's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biotricity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryApyx Medical beats Biotricity on 14 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.27M$4.41B$5.40B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E Ratio-0.2438.74115.5615.18Price / Sales0.7765.071,484.3492.77Price / CashN/A49.1039.6634.07Price / Book-0.124.264.665.02Net Income-$14.09M$11.52M$119.06M$225.46M7 Day Performance-9.09%1.04%0.80%0.37%1 Month Performance36.67%0.92%5.65%3.57%1 Year Performance-59.41%39.40%36.76%29.44% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.41flatN/A-59.0%$9.27M$12.06M-0.2440APYXApyx Medical4.5083 of 5 stars$1.17-4.9%$5.00+327.4%-49.1%$40.53M$49.03M-1.43270Upcoming EarningsPositive NewsGap UpCODXCo-Diagnostics3.2307 of 5 stars$1.18-3.3%$1.50+27.1%+13.1%$37.66M$9.14M-0.94100Upcoming EarningsShort Interest ↑SURGSurgePays3.6282 of 5 stars$1.52-0.9%$9.00+491.7%-64.2%$30.04M$137.14M16.9022News CoverageFEMYFemasys3.4353 of 5 stars$1.35-0.7%$10.67+690.1%-9.4%$30.02M$950,096.00-1.6330Analyst ForecastNews CoverageSTIMNeuronetics2.5995 of 5 stars$0.99-7.5%$4.67+371.4%-10.4%$29.70M$72.07M-0.88180News CoverageDRIODarioHealth2.1152 of 5 stars$0.98-1.8%$4.00+308.2%-6.2%$29.33M$19.15M-0.83200Upcoming EarningsOMOutset Medical2.2779 of 5 stars$0.53-1.6%$4.70+785.1%-83.8%$27.66M$116.43M-0.17520Upcoming EarningsMDAISpectral AI2.4251 of 5 stars$1.53-2.2%$4.50+195.1%-51.5%$26.66M$22.53M-1.1478Upcoming EarningsXAIRBeyond Air4.5286 of 5 stars$0.57+10.2%$3.67+541.1%-79.0%$26.61M$1.78M-0.3570Gap DownNXLNexalin Technology1.364 of 5 stars$2.43+6.6%$3.00+23.5%+887.5%$25.73M$150,159.00-3.373News CoverageGap Up Related Companies and Tools Related Companies Apyx Medical Alternatives Co-Diagnostics Alternatives SurgePays Alternatives Femasys Alternatives Neuronetics Alternatives DarioHealth Alternatives Outset Medical Alternatives Spectral AI Alternatives Beyond Air Alternatives Nexalin Technology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTCY) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
